-
BioTime Inc. (BTX)
- P/E (TTM): 2.0X
- View BTX Profile
- View Questions on BTX
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Costco Wholesale Corporation (COST $1,010.79)
- $1,010.79 P/E (TTM): 68.52X Cap: $437.98B
- View COST Profile
- View Questions on COST
-
Intuitive Surgical Inc. (ISRG $503.51)
- $503.51 P/E (TTM): 62.53X Cap: $180B
- View ISRG Profile
- View Questions on ISRG
-
NVIDIA Corporation (NVDA $177.19)
- $177.19 P/E (TTM): 47.53X Cap: $4.49T
- View NVDA Profile
- View Questions on NVDA
-
Booking Holdings Inc. (BKNG $4,239.35)
- $4,239.35 P/E (TTM): 23.3X Cap: $134.61B
- View BKNG Profile
- View Questions on BKNG
-
Eli Lilly and Company (LLY $1,051.99)
- $1,051.99 P/E (TTM): 46.12X Cap: $964.13B
- View LLY Profile
- View Questions on LLY
-
BioTime Inc. (BTX)
- P/E (TTM): 2.0X
- View BTX Profile
- View Questions on BTX
-
Microsoft CDR (CAD Hedged) (MSFT $27.95)
- $27.95 P/E (TTM): 29.12X Cap: $4.06T
- View MSFT Profile
- View Questions on MSFT
Q: I currently hold MSFT, NVIDIA and COST in my TFSA. I took a loss on BTX and now have cash to reinvest.
Should I buy more of the above 3 or diversify and if so any suggestions without making specific recommendations
Should I buy more of the above 3 or diversify and if so any suggestions without making specific recommendations
Insiders
Share Information
SEC Filings
News and Media